Literature DB >> 34158188

Acute generalized exanthematous pustulosis induced by atezolizumab in a patient with lung adenocarcinoma.

Hua-Ching Chang1, Po-Huan Ko1, Yin-Shuo Chang2, Pai-Chien Chou3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34158188     DOI： 10.1016/j.lungcan.2021.06.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  3 in total

1.  Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report.

Authors:  Pierre Magdelaine; Adrien Costantini; Lucie Fabre; Etienne Giroux-Leprieur
Journal:  Thorac Cancer       Date:  2022-05-26       Impact factor: 3.223

Review 2.  Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article.

Authors:  Chieh-Hsun Chen; Hsin-Su Yu; Sebastian Yu
Journal:  Curr Oncol       Date:  2022-04-18       Impact factor: 3.109

Review 3.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.